UK-356618 is a matrix metalloproteinase-3 (MMP-3) inhibitor. References: Hafez S, Abdelsaid M, El-Shafey S, Johnson MH, Fagan SC, Ergul A. Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke. Stroke. 2016 Mar;47(3):843-51. doi: 10.1161/STROKEAHA.115.011258. Epub 2016 Feb 2. PubMed PMID: 26839355; PubMed Central PMCID: PMC4766051.

纯度：≥98%

CAS：230961-08-7